Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: GLORIA PHARMA.(002437) the Revenue is 467.96 M (-14.64%);the EBIT is 92.06 M (+45.34%);the EPS is 0.0287 (-13.11%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.47B14.64%
----
----
EBIT
0.09B45.34%
----
----
EPS
0.028713.11%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf